184 related articles for article (PubMed ID: 31635932)
21. Inhibition of Aβ(1-40) fibril formation by cyclophilins.
Villmow M; Baumann M; Malesevic M; Sachs R; Hause G; Fändrich M; Balbach J; Schiene-Fischer C
Biochem J; 2016 May; 473(10):1355-68. PubMed ID: 26994210
[TBL] [Abstract][Full Text] [Related]
22. Pyrrolidine-5,5-trans-lactams. 2. The use of X-ray crystal structure data in the optimization of P3 and P4 substituents.
Andrews DM; Chaignot H; Coomber BA; Good AC; Hind SL; Johnson MR; Jones PS; Mills G; Robinson JE; Skarzynski T; Slater MJ; Somers DO
Org Lett; 2002 Dec; 4(25):4479-82. PubMed ID: 12465917
[TBL] [Abstract][Full Text] [Related]
23. Cyclophilin D links programmed cell death and organismal aging in Podospora anserina.
Brust D; Daum B; Breunig C; Hamann A; Kühlbrandt W; Osiewacz HD
Aging Cell; 2010 Oct; 9(5):761-75. PubMed ID: 20626725
[TBL] [Abstract][Full Text] [Related]
24. Novel prostaglandin D synthase inhibitors generated by fragment-based drug design.
Hohwy M; Spadola L; Lundquist B; Hawtin P; Dahmén J; Groth-Clausen I; Nilsson E; Persdotter S; von Wachenfeldt K; Folmer RH; Edman K
J Med Chem; 2008 Apr; 51(7):2178-86. PubMed ID: 18341273
[TBL] [Abstract][Full Text] [Related]
25. Integrated biophysical approach to fragment screening and validation for fragment-based lead discovery.
Silvestre HL; Blundell TL; Abell C; Ciulli A
Proc Natl Acad Sci U S A; 2013 Aug; 110(32):12984-9. PubMed ID: 23872845
[TBL] [Abstract][Full Text] [Related]
26. Combining NMR and X-ray crystallography in fragment-based drug discovery: discovery of highly potent and selective BACE-1 inhibitors.
Wyss DF; Wang YS; Eaton HL; Strickland C; Voigt JH; Zhu Z; Stamford AW
Top Curr Chem; 2012; 317():83-114. PubMed ID: 21647837
[TBL] [Abstract][Full Text] [Related]
27. Cyclophilin inhibition as potential therapy for liver diseases.
Naoumov NV
J Hepatol; 2014 Nov; 61(5):1166-74. PubMed ID: 25048953
[TBL] [Abstract][Full Text] [Related]
28. Deconstructing fragment-based inhibitor discovery.
Babaoglu K; Shoichet BK
Nat Chem Biol; 2006 Dec; 2(12):720-3. PubMed ID: 17072304
[TBL] [Abstract][Full Text] [Related]
29. Fragments as Novel Starting Points for tRNA-Guanine Transglycosylase Inhibitors Found by Alternative Screening Strategies.
Hassaan E; Eriksson PO; Geschwindner S; Heine A; Klebe G
ChemMedChem; 2020 Feb; 15(3):324-337. PubMed ID: 31808981
[TBL] [Abstract][Full Text] [Related]
30. Structure-based optimization of hydroxylactam as potent, cell-active inhibitors of lactate dehydrogenase.
Wei B; Robarge K; Labadie SS; Chen J; Corson LB; DiPasquale A; Dragovich PS; Eigenbrot C; Evangelista M; Fauber BP; Hitz A; Hong R; Lai KW; Liu W; Ma S; Malek S; O'Brien T; Pang J; Peterson D; Salphati L; Sampath D; Sideris S; Ultsch M; Xu Z; Yen I; Yu D; Yue Q; Zhou A; Purkey HE
Bioorg Med Chem Lett; 2022 Mar; 59():128576. PubMed ID: 35065235
[TBL] [Abstract][Full Text] [Related]
31. Creating novel activated factor XI inhibitors through fragment based lead generation and structure aided drug design.
Fjellström O; Akkaya S; Beisel HG; Eriksson PO; Erixon K; Gustafsson D; Jurva U; Kang D; Karis D; Knecht W; Nerme V; Nilsson I; Olsson T; Redzic A; Roth R; Sandmark J; Tigerström A; Öster L
PLoS One; 2015; 10(1):e0113705. PubMed ID: 25629509
[TBL] [Abstract][Full Text] [Related]
32. Fragment-Based Drug Discovery: Advancing Fragments in the Absence of Crystal Structures.
Erlanson DA; Davis BJ; Jahnke W
Cell Chem Biol; 2019 Jan; 26(1):9-15. PubMed ID: 30482678
[TBL] [Abstract][Full Text] [Related]
33. Identification of a new series of potent diphenol HSP90 inhibitors by fragment merging and structure-based optimization.
Ren J; Li J; Wang Y; Chen W; Shen A; Liu H; Chen D; Cao D; Li Y; Zhang N; Xu Y; Geng M; He J; Xiong B; Shen J
Bioorg Med Chem Lett; 2014 Jun; 24(11):2525-9. PubMed ID: 24751441
[TBL] [Abstract][Full Text] [Related]
34. Small-Molecule Inhibitors of Cyclophilins Block Opening of the Mitochondrial Permeability Transition Pore and Protect Mice From Hepatic Ischemia/Reperfusion Injury.
Panel M; Ruiz I; Brillet R; Lafdil F; Teixeira-Clerc F; Nguyen CT; Calderaro J; Gelin M; Allemand F; Guichou JF; Ghaleh B; Ahmed-Belkacem A; Morin D; Pawlotsky JM
Gastroenterology; 2019 Nov; 157(5):1368-1382. PubMed ID: 31336123
[TBL] [Abstract][Full Text] [Related]
35. Exploitation of a Novel Binding Pocket in Human Lipoprotein-Associated Phospholipase A2 (Lp-PLA2) Discovered through X-ray Fragment Screening.
Woolford AJ; Pero JE; Aravapalli S; Berdini V; Coyle JE; Day PJ; Dodson AM; Grondin P; Holding FP; Lee LY; Li P; Manas ES; Marino J; Martin AC; McCleland BW; McMenamin RL; Murray CW; Neipp CE; Page LW; Patel VK; Potvain F; Rich S; Rivero RA; Smith K; Somers DO; Trottet L; Velagaleti R; Williams G; Xie R
J Med Chem; 2016 Jun; 59(11):5356-67. PubMed ID: 27167608
[TBL] [Abstract][Full Text] [Related]
36. Discovery of a Potent Class I Protein Arginine Methyltransferase Fragment Inhibitor.
Ferreira de Freitas R; Eram MS; Szewczyk MM; Steuber H; Smil D; Wu H; Li F; Senisterra G; Dong A; Brown PJ; Hitchcock M; Moosmayer D; Stegmann CM; Egner U; Arrowsmith C; Barsyte-Lovejoy D; Vedadi M; Schapira M
J Med Chem; 2016 Feb; 59(3):1176-83. PubMed ID: 26824386
[TBL] [Abstract][Full Text] [Related]
37. Use of a real-time fluorescence monitoring system for high-throughput screening for prolyl isomerase inhibitors.
Mori T; Itami S; Yanagi T; Tatara Y; Takamiya M; Uchida T
J Biomol Screen; 2009 Apr; 14(4):419-24. PubMed ID: 19403925
[TBL] [Abstract][Full Text] [Related]
38. Efficient search of chemical space: navigating from fragments to structurally diverse chemotypes.
Wassermann AM; Kutchukian PS; Lounkine E; Luethi T; Hamon J; Bocker MT; Malik HA; Cowan-Jacob SW; Glick M
J Med Chem; 2013 Nov; 56(21):8879-91. PubMed ID: 24117015
[TBL] [Abstract][Full Text] [Related]
39. Identification of B. anthracis N(5)-carboxyaminoimidazole ribonucleotide mutase (PurE) active site binding compounds via fragment library screening.
Lei H; Jones C; Zhu T; Patel K; Wolf NM; Fung LW; Lee H; Johnson ME
Bioorg Med Chem; 2016 Feb; 24(4):596-605. PubMed ID: 26740153
[TBL] [Abstract][Full Text] [Related]
40. Computational insight into small molecule inhibition of cyclophilins.
Sambasivarao SV; Acevedo O
J Chem Inf Model; 2011 Feb; 51(2):475-82. PubMed ID: 21194235
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
